| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |